Nanomol
    Technologies

  • The company
  • Successful cases
  • R+D
  • Clients
  • News
  • Contact

    Particle
    technologies

  • Delos enabled products
  • Benefits and advantages
  • Partnering
  • Delos nanovesicles
  • Solid particulate materials

    Contract
    analysis

  • Services
  • Analysis
  • Quality
  • Expertise and equipment
Back to the gallery

News

DELOS based nanoformulation for Fabry Disease designed as Orphan Drug
28 February 2021

DELOS based nanoformulation for Fabry Disease designed as Orphan Drug

In the Day of Rare Diseases, we want to share the excellent news of Orphan Drug designation by the EMA of the novel nanomedicine developed in Smart4Fabry project. This nanomedicine, based on peptide targeted nanoliposomes containing alpha-galactosidase A is formulated with our DELOS nanoformulation platform. Nanomol Technologies team has optimized, scaled-up and produced the required batches for regulatory preclinical testing using a Quality by Design approach. In the video below the project coordinator Nora Ventosa from CIBER-BBN and one of our founders summarizes this achievement.


Excellent results for an excellent international teamwork! INSTITUT DE CIÈNCIA DE MATERIALS DE BARCELONA (ICMAB-CSIC), CIBER-BBN, Vall d’Hebron Institute of Research (VHIR) - Vall d'Hebron Institut de Recerca, IQAC-CSIC, Leanbio, DDR drug Development and Regulation, Technion - Israel Institute of Technology, Aarhus University, Joanneum Research, BNN-Bionanonet, Biokeralty and Covance.


https://youtu.be/VSDkAVBrLA8


www.smart4fabry.eu


#pushingnanomedicinesforward #addingvaluetoyourmolecules

Related
news

Nanomol Technologies has been Advertised on the “Spotlight on Catalonia” of Nature Journal 15 December 2016

Nanomol Technologies has been Advertised on the “Spotlight on Catalonia” of Nature Journal

NANOMOL TECHNOLOGIES IS OFFICIAL PARTNER OF 12TH GLOBAL DDF SUMMIT DRUG DELIVERY & FORMULATION 16 March 2021

NANOMOL TECHNOLOGIES IS OFFICIAL PARTNER OF 12TH GLOBAL DDF SUMMIT DRUG DELIVERY & FORMULATION

NANOMOL TECHNOLOGIES HAS STARTED THE TECNIOSPRING PLUS PROJECT (TECSPR18-1-0016) 16 May 2019

NANOMOL TECHNOLOGIES HAS STARTED THE TECNIOSPRING PLUS PROJECT (TECSPR18-1-0016)

come and visit us

NANOMOL TECHNOLOGIES, S.L.
Mòdul de Recerca B
UAB CAMPUS

08193 Bellaterra
Cerdanyola del Vallès
Barcelona
Spain

get in touch

T +34 935 868 963
INFO@NANOMOL-TECH.COM

follow us

Twitter Linkedin

terms of use

Privacy policy Legality

Copyright © 2021

Nanomol Technologies S.L.

Site by Suki

This website uses cookies.